干细胞在糖尿病和糖尿病并发症中的重编程:最近的进展
Hafez R Madkor1, Mostafa K Abd El-Aziz2, Mostafa S Abd El-Maksoud2
1Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, 71524, Egypt.
Current diabetes reviews
|January 4, 2024
概括
干细胞治疗为治疗糖尿病及其并发症提供了一个有前途的新途径. 研究探索各种干细胞类型,以产生胰岛素产生细胞,解决当前治疗方法的局限性.
科学领域:
- 再生医学是一种再生医学.
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
背景情况:
- 糖尿病 (DM) 的全球发病率正在上升,预计到2045年将达到7亿.
- 在DM中不受控制的高血糖会导致严重的并发症,如脏病,视网膜病,神经病和心血管疾病.
- 糖尿病显著影响医疗保健经济,生活质量,发病率和死亡率,特别是在发展中国家.
研究的目的:
- 审查糖尿病治疗的干细胞 (SC) 研究的最新进展.
- 突出SC疗法在管理DM及其相关并发症方面的潜在好处.
- 为研究人员提供有关糖尿病护理中干细胞应用的不断变化的信息.
主要方法:
- 探索干细胞 (SC) 治疗作为传统胰岛素和口服抗糖尿病药物的替代品.
- 研究各种SC类型的使用,包括胚胎干细胞 (ESC),诱导多能干细胞 (iPSC) 和成人干细胞 (胰腺,肝脏,介质干细胞 - MSC).
- 对不同SCs分化成产生胰岛素的细胞的能力进行分析,以潜在的治疗应用.
主要成果:
- 干细胞 (SC) 疗法在治疗一型DM (T1DM) 和二型DM (T2DM) 方面显示出有前途的结果.
- SCs已经显示出减轻各种糖尿病并发症的潜力.
- 不同类型的干细胞 (ESC,iPSC,MSC) 可以发展成产生胰岛素的细胞,尽管每种都存在独特的局限性.
结论:
- 干细胞研究为新型糖尿病 (DM) 治疗提供了显著的潜力.
- 对干细胞分化和应用的进一步研究对于克服当前治疗挑战至关重要.
- 干细胞疗法代表了管理糖尿病和预防其衰弱并发症的前沿.
更多相关视频
06:33Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
Published on: February 2, 2024
1.9K
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
2.9K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Tissue Renewal without Stem Cells
1.7K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.7K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
